Compile Data Set for Download or QSAR
maximum 50k data
Found 63 with Last Name = 'lindenschmidt' and Initial = 'a'
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120796(US8710232, 33)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446804(CHEMBL3115061)
Affinity DataIC50:  4nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120790(US8710232, 17)
Affinity DataIC50:  11nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446821(CHEMBL3115056)
Affinity DataIC50:  12nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120788(US8710232, 15)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120787(US8710232, 13)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120786(US8710232, 12)
Affinity DataIC50:  15nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120782(US8710232, 7)
Affinity DataIC50:  16nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120791(US8710232, 18)
Affinity DataIC50:  21nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120785(US8710232, 10)
Affinity DataIC50:  23nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120781(US8710232, 1)
Affinity DataIC50:  30nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-1/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446804(CHEMBL3115061)
Affinity DataIC50:  33nMAssay Description:Antagonist activity at integrin alpha1beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen type-1 after 3...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446818(CHEMBL3115059)
Affinity DataIC50:  34nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446811(CHEMBL3115067)
Affinity DataIC50:  36nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120789(US8710232, 16)
Affinity DataIC50:  38nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446820(CHEMBL3115057)
Affinity DataIC50:  38nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120797(US8710232, 37)
Affinity DataIC50:  49nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446804(CHEMBL3115061)
Affinity DataIC50:  74nMAssay Description:Antagonist activity at integrin alpha5beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen type-1 after 3...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446837(CHEMBL3114869)
Affinity DataIC50:  101nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446838(CHEMBL3114868)
Affinity DataIC50:  106nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446845(CHEMBL3114861)
Affinity DataIC50:  114nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446823(CHEMBL3115054)
Affinity DataIC50:  134nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446843(CHEMBL3114863)
Affinity DataIC50:  142nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446846(CHEMBL3114860)
Affinity DataIC50:  163nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446805(CHEMBL3115073)
Affinity DataIC50:  176nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446839(CHEMBL3114867)
Affinity DataIC50:  178nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50117069((S)-2-(2-Chloro-6-methyl-benzoylamino)-3-[4-(2,6-d...)
Affinity DataIC50:  214nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446844(CHEMBL3114862)
Affinity DataIC50:  233nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446807(CHEMBL3115071)
Affinity DataIC50:  270nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446816(CHEMBL3115062)
Affinity DataIC50:  366nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120784(US8710232, 9)
Affinity DataIC50:  439nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446815(CHEMBL3115063)
Affinity DataIC50:  470nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446817(CHEMBL3115060)
Affinity DataIC50:  497nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446842(CHEMBL3114864)
Affinity DataIC50:  588nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446827(CHEMBL3115050)
Affinity DataIC50:  667nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446806(CHEMBL3115072)
Affinity DataIC50:  731nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446836(CHEMBL3114870)
Affinity DataIC50:  731nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446834(CHEMBL3114872)
Affinity DataIC50:  745nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446822(CHEMBL3115055)
Affinity DataIC50:  792nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446812(CHEMBL3115066)
Affinity DataIC50:  869nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120795(US8710232, 31)
Affinity DataIC50:  870nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446814(CHEMBL3115064)
Affinity DataIC50:  909nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446841(CHEMBL3114865)
Affinity DataIC50:  978nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446830(CHEMBL3114876)
Affinity DataIC50: >1.00E+3nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446829(CHEMBL3114877)
Affinity DataIC50: >1.00E+3nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446825(CHEMBL3115052)
Affinity DataIC50: >1.00E+3nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446824(CHEMBL3115053)
Affinity DataIC50: >1.00E+3nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446832(CHEMBL3114874)
Affinity DataIC50: >1.00E+3nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-2/beta-1(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50446833(CHEMBL3114873)
Affinity DataIC50:  1.05E+3nMAssay Description:Antagonist activity at recombinant integrin alpha2 beta1 receptor (unknown origin) assessed as inhibition of interaction with biotinylated collagen t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120793(US8710232, 27)
Affinity DataIC50:  1.11E+3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: